Here’s What’s Driving Crispr Therapeutics AG Higher Today – Motley Fool
Norman Weekly |
Here's What's Driving Crispr Therapeutics AG Higher Today
Motley Fool In the U.S., Crispr Therapeutics and its peers are still awaiting regulatory reviews that would allow them to begin human testing with their first new therapy candidates. Perhaps fearing international condemnation for playing fast and loose with … Crispr Therapeutics (CRSP) Lifted to Buy at SunTrust Banks Analyst Upgrades – Crispr Therapeutics (NASDAQ:CRSP) Stock Gets Upgraded By SunTrust Banks from Hold to Buy Stocks that can influence your investment – CRISPR Therapeutics AG (NASDAQ:CRSP) |
